Invesco Ltd. - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 74 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2024$23,948
+35.2%
34,507
-0.1%
0.00%
Q4 2023$17,713
-58.7%
34,543
+19.1%
0.00%
Q3 2023$42,917
-7.6%
28,998
+0.5%
0.00%
Q2 2023$46,461
-50.6%
28,858
-11.0%
0.00%
Q1 2023$94,027
-59.6%
32,423
-54.3%
0.00%
Q4 2022$232,868
-14.1%
70,996
-0.8%
0.00%
Q3 2022$271,000
-52.6%
71,587
-2.5%
0.00%
Q2 2022$572,000
-5.1%
73,403
+13.0%
0.00%
Q1 2022$603,000
-18.7%
64,934
+38.0%
0.00%
Q4 2021$742,000
-20.5%
47,048
-9.6%
0.00%
Q3 2021$933,000
+25.2%
52,068
+8.7%
0.00%
Q2 2021$745,000
+43.5%
47,917
+32.5%
0.00%
Q1 2021$519,000
-30.8%
36,159
-5.3%
0.00%
Q4 2020$750,000
+110.1%
38,200
+38.9%
0.00%
Q3 2020$357,000
-12.7%
27,501
-2.2%
0.00%
Q2 2020$409,000
+54.9%
28,122
-9.3%
0.00%
Q1 2020$264,000
-23.5%
31,014
+62.5%
0.00%
Q4 2017$345,000
+10.9%
19,088
+1.6%
0.00%
Q3 2017$311,000
+23.9%
18,791
+5.0%
0.00%
Q2 2017$251,000
-31.4%
17,903
+0.4%
0.00%
Q1 2017$366,000
-84.5%
17,834
-83.8%
0.00%
-100.0%
Q3 2016$2,357,000
-5.0%
110,172
-0.0%
0.00%0.0%
Q2 2016$2,480,000
+18.3%
110,197
+0.0%
0.00%0.0%
Q1 2016$2,097,000
-27.9%
110,1730.0%0.00%0.0%
Q4 2015$2,910,000
-15.9%
110,173
+0.1%
0.00%0.0%
Q3 2015$3,462,000
+69140.0%
110,098
+107839.2%
0.00%
Q2 2015$5,0001020.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 2,246,401$19,117,0002.21%
Antipodean Advisors LLC 221,000$1,881,0001.74%
Trellus Management Company, LLC 110,000$936,0001.68%
Redmile Group, LLC 5,293,370$45,047,0001.26%
Baupost Group 8,308,900$70,709,0001.04%
MAVERICK CAPITAL LTD 5,199,897$44,251,0000.93%
Artal Group S.A. 2,500,000$21,275,0000.90%
Camber Capital Management LP 1,478,753$12,584,0000.75%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 253,000$2,839,0000.48%
Slate Path Capital LP 420,000$3,574,0000.27%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders